KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Total Current Liabilities (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Total Current Liabilities data on record, last reported at $6.9 billion in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 19.0% year-over-year to $6.9 billion; the TTM value through Dec 2025 reached $6.9 billion, up 19.0%, while the annual FY2025 figure was $6.9 billion, 19.0% up from the prior year.
  • Total Current Liabilities reached $6.9 billion in Q4 2025 per CL's latest filing, up from $6.5 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $6.9 billion in Q1 2025 and bottomed at $4.0 billion in Q4 2022.
  • Average Total Current Liabilities over 5 years is $5.1 billion, with a median of $4.6 billion recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: dropped 8.23% in 2021, then grew 29.11% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $4.1 billion in 2021, then fell by 1.16% to $4.0 billion in 2022, then increased by 18.41% to $4.7 billion in 2023, then rose by 21.47% to $5.8 billion in 2024, then increased by 19.0% to $6.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $6.9 billion in Q4 2025, $6.5 billion in Q3 2025, and $6.8 billion in Q2 2025.